Trial site
Augusta University, Georgia Cancer Center
- 11running trials
- 4closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Childhood cancers3 trials
- Ovarian cancer3 trials
- Triple-negative breast cancer3 trials
- Acute myeloid leukaemia2 trials
- Endometrial cancer2 trials
- Glioblastoma2 trials
- Melanoma2 trials
- Multiple myeloma2 trials
- Acute lymphoblastic leukaemia1 trial
- Cervical cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- and 4 more
- Phase
- Phase 15 trials
- Phase 23 trials
- Phase 33 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Recruiting4 trials
- Completed3 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- BioAtla, Inc.2 trials
- Genmab2 trials
- Theodore S. Johnson2 trials
- Allogene Therapeutics1 trial
- Caribou Biosciences, Inc.1 trial
- and 7 more
Running trials
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Active, not recruiting
Active, not recruiting
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Enrolling by invitation
Recruiting
Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Active, not recruiting
Active, not recruiting
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Childhood cancers2 recruiting
- Cervical cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Glioblastoma1 recruiting
- Lung cancer1 recruiting
- Mesothelioma1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026